# China NMPA Drug Inspection - Zhuhai Federal Pharmaceutical Co., Ltd. - Amoxicillin sodium clavulanate potassium (5:1)

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/zhuhai-federal-pharmaceutical-co-ltd/d363b4be-f14b-49c8-8212-8ec37d36809d/
Source feed: China

> China NMPA drug inspection for Zhuhai Federal Pharmaceutical Co., Ltd. published July 28, 2022. Drug: Amoxicillin sodium clavulanate potassium (5:1). 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 1, 2022)
- Company Name: Zhuhai Federal Pharmaceutical Co., Ltd.
- Publication Date: 2022-07-28
- Drug Name: Amoxicillin sodium clavulanate potassium (5:1)
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/zhuhai-federal-pharmaceutical-co-ltd/bb4825c4-f115-47da-9153-e81b46bcc131/